CTOs on the Move

Trevi Therapeutics

www.trevitherapeutics.com

 
Trevi Therapeutics, Inc. is a late-stage clinical development company developing Nalbuphine® ER for chronic pruritus (itch). Pruritus develops in various dermatologic, metabolic, hematologic, and neuropathic conditions. The Company is pursuing two conditions for clinical development: uremic pruritus and prurigo nodularis. Uremic pruritus is a persistent and debilitating itch in patients on dialysis that has been associated with significant impairment in quality of life and increased mortality. Prurigo nodularis is an intensely pruritic dermatologic condition characterized by unsightly and itchy skin papules and nodules. There are no approved therapies in the United States or Europe for either condition.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Trevi Therapeutics raised $50.5M on 07/20/2017
Trevi Therapeutics raised $55M on 04/07/2022

Similar Companies

Tiba Medical

Tiba Medical is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CareLink Community Support Services

CareLink Community Services provides a progressive approach to rehabilitation, wellness, & autonomy for people with disabilities.

Nanōmix

Nanōmix is the leader in mobile point-of-care diagnostics for use where time and accuracy is critical.

far east summit

far east summit is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Isto Biologics

Isto Biologics is an orthobiologics company dedicated to helping patients heal faster through advanced solutions for spine, orthopedics, sports and regenerative medicine.